Dipcan, a multi-omics intelligence platform for personalized medicine in oncology

Dipcan is the largest publicly funded project in Spain for an artificial intelligence (AI) oncology platform. It harmonized over 60 TB of data from more than 130 hospitals, integrating more than 29 different health data types sources.

Challenge

To take a step further in personalized cancer medicine by integrating clinical, genomic, anatomopathological, and radiomic data, using AI models to choose the most appropriate treatment.

Solution

A multimodal platform to store, process and integrate all patient datasets in a single centralized repository for AI modeling, with a focus on continuous and iterative model training.

Results

The project is expected to provide objective guidance for individual clinical management but also to help develop national health strategies to prevent, early diagnose and treat the most prevalent tumors in a more cost-effective way.

Location

Spain

About

The project has the presence of Eurofins Megalab, MD Anderson International Foundation Spain and five SMEs, and counts with €7,5M in funding from the European Union through the Spanish Ministry of Economic Affairs and Digital Transformation.

features used in this project

Compliance & Security
Genomic Analysis
Interface Builder
Platform Engine
Unified Multimodal Datastore

Project

Collaborative omic data integration: advancing in precision oncology

Multidisciplinary cancer care needs holistic views, integrating omic data. Individual data is insufficient, but integration clarifies disease causes and treatment responses. Complex data standardization is vital. The Dipcan App streamlines patient registration, data retrieval, and follow-up. It provides PDF reports and facilitates communication. Data is automatically saved and structured on Genomcore's platform, enabling AI modeling and custom workflows.

Genomcore’s platform offers a GDPR and HIPAA-compliant framework for the store, management, standardization and integration of all kinds of datasets.

Multi-omics data has the potential to redefine the precision oncology paradigm. Dipcan is a project where 7 leading institutions in Spain join forces to enhance the understanding of cancer in individual patients for earlier and more accurate diagnosis, targeted treatment, and a multidimensional analysis of tumor data. Here, the AI models contribute to the development of national health strategies to manage these diseases in a more cost-effective manner.

“I believe the time has come to systematize the collection of this data in an intuitive, agile way that does not depend so much on the subjectivity of the doctor collecting it, and that specially will allow us to analyze and interpret this data in the future.”

Dr. Enrique Grande, the Principal Investigator and Head of the Medical Oncology Service and Clinical Research at the MD Anderson Cancer Center Madrid Foundation.